Materialise: Medical And Software-Led Rebound

Materialise is poised for a return to consistent growth and improving margins, led by Medical strength and stabilization of its Software business. The Manufacturing segment faces ongoing headwinds, but expansion into aerospace and defense could create a modest rebound over the next few years. The combination of a low valuation, consistent growth, and higher margins should lead the stock higher, which will be supported by a share buyback program.

Seeking Alpha • 10 hours ago

Materialise NV (MTLS) Q4 2025 Earnings Call Transcript

Materialise NV (MTLS) Q4 2025 Earnings Call Transcript

Seeking Alpha • Feb 19, 2026

Materialise Reports Fourth Quarter and Full Year 2025 Results

LEUVEN, Belgium--(BUSINESS WIRE)---- $MTLS--Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the fourth quarter and full year ended December 31, 2025. Highlights – Fourth Quarter 2025 Total revenue increased by 6.8% to 70,164 kEUR for the fourth quarter of 2025 from 65,680 kEUR for the corresponding 2024 period, boosted by 16.3% growth in our Mat.

Business Wire • Feb 19, 2026

Materialise NV to Report Fourth Quarter 2025 Earnings on Thursday, February 19, 2026

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced that it will release financial results for the fourth quarter ended December 31, 2025 on Thursday, February 19, 2026 at 2:30 a.m. ET/8:30 a.m. CET. Senior management will hold a conference call to discuss the fourth quarter 2025 financial results on Thursday, February 19, 2026 at.

Business Wire • Feb 4, 2026

Materialise (MTLS) Upgraded to Strong Buy: What Does It Mean for the Stock?

Materialise (MTLS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks Investment Research • Dec 18, 2025

New Strong Buy Stocks for Dec. 18: MTLS, AMX, and More

JRVR, CALX, MTLS, AMX and NWFL have been added to the Zacks Rank #1 (Strong Buy) List on Dec. 18, 2025.

Zacks Investment Research • Dec 18, 2025

Best Momentum Stocks to Buy for Dec. 18

MTLS, CALX and AA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on Dec. 18, 2025.

Zacks Investment Research • Dec 18, 2025

New Strong Buy Stocks for December 2nd

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Zacks Investment Research • Dec 2, 2025

Materialise Successfully Launched on Euronext Brussels – Information on the Total Number of Voting Rights and Shares

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & Nasdaq: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced the start of its additional listing of its ordinary shares on Euronext Brussels, to complement the existing Nasdaq listing of its American depositary shares (ADSs) representing ordinary shares. The additional listing and trading of the Materialise shares on Euronext Brussels will.

Business Wire • Nov 20, 2025

Best Momentum Stock to Buy for Oct. 31st

AGYS, KALU and MTLS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 31, 2025.

Zacks Investment Research • Oct 31, 2025